Addressing legal and political barriers to global pharmaceutical access: Options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards

  title={Addressing legal and political barriers to global pharmaceutical access: Options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards},
  author={J. C. Cohen-Kohler and L. Forman and Nathaniel B Lipkus},
  journal={Health Economics, Policy and Law},
  pages={229 - 256}
Abstract Despite myriad programs aimed at increasing access to essential medicines in the developing world, the global drug gap persists. This paper focuses on the major legal and political constraints preventing implementation of coordinated global policy solutions – particularly, the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and bilateral and regional free trade agreements. We argue that several policy and research routes should be taken to mitigate the… Expand
Framing and Reframing Global Patent Policy
  • 2009
This paper pursues an analysis of the global pharmaceutical patent policy discourse and the inception of the Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement. It argues that aExpand
Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries
If the debate on initiatives for increased flexibility of intellectual property rights does not become more extensive or obtain the overwhelming support of the international community, serious consequences are to be expected in terms of the fight against AIDS in most of the developing countries. Expand
Pros and Cons of Compulsory Licensing: An Analysis of Arguments
Patents provide monopoly rights to patent owners to manufacture, sell, and import the product resulting in overpricing of the patented products. Without patents, the inventors and innovators canExpand
Assessing 15 proposals for promoting innovation and access to medicines globally.
No one solution was deemed a panacea, as many (often competing) considerations need to be taken into account, but some proposals appeared more promising and feasible at this time and deserve further attention. Expand
Globalization, Human Rights, and the Social Determinants of Health
The potential contributions and limitations of human rights to achieving greater equity in shaping the social determinants of health are reviewed. Expand
Access to critical medicines: When are compulsory licenses effective in price negotiations?
A game theoretic model of such bargaining is developed and it is shown that while compulsory licenses do not occur under complete information, they can be issued under incomplete information. Expand
The Centrality of Intellectual Property Law in the Fight Against Ebola Virus in West Africa.
The Ebola epidemic appears the greatest ever recorded in human history, affecting several countries of West Africa. The outbreak has raised a lot of alarm around the world as what was perceived as aExpand
Improving access to HIV/AIDS treatment in Brazil : when are compulsory licenses effective in price negotiations?
Since 1996, Brazil has an anti-AIDS programme that offers universal and free access to antiretroviral through the public-sector health system. An important part of the successful implementation ofExpand
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis
  • K. Son
  • Business, Medicine
  • Globalization and Health
  • 2019
Evidence of an association between attempting compulsory licensing and matured patent systems is provided by demonstrating that countries with a mature patent system were more likely to utilize compulsory licensing of pharmaceuticals. Expand
Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
PEPFAR's evolving use of generic antiretroviral drugs to treat HIV in the developing world is outlined, ongoing initiatives to increase access are highlighted, and the need for mechanisms that will speed up the approval of new generic drugs is pointed to. Expand


Making Access to Pharmaceuticals a Reality: Legal Options under TRIPS and the Case of Brazil
The HIV/AIDS epidemic has made the problem of access to pharmaceuticals in developing countries a subject of intense public debate. This Essay contends that tensions between intellectual propertyExpand
WTO TRIPS Agreement and its Implications for Access to Medicines in Developing Countries
This study accepts the consensus of experts that developing countries should make use of policy options such as compulsory licensing and parallel importation to increase the supply of low-priceExpand
Trade Rules, Intellectual Property, and the Right to Health
  • L. Forman
  • Economics
  • Ethics & International Affairs
  • 2007
In perpetuating and exacerbating restricted access to essential medicines, current trade-related intellectual property rules on medicines may violate core human rights to health and medicines. InExpand
Public Health and Intellectual Property Rights
The recognition and enforcement of patents in developing countries has raised considerable controversy, particularly in relation to the implications of patents for access to drugs. Questions haveExpand
The effects of extending intellectual property rights protection to developing countries: A case study of the Indian pharmaceutical market
Under the TRIPS agreement, WTOmembers are required to enforce product patents for pharmaceuticals. The debate about the merits of this requirement has been and continues to be extremely contentious.Expand
Pharmaceutical Arbitrage: Balancing Access and Innovation in International Prescription Drug Markets
  • K. Outterson
  • Economics, Medicine
  • Yale journal of health policy, law, and ethics
  • 2005
The heuristic of globally optimal appropriation alters some of the received wisdom on pharmaceutical pricing, suggesting that nonrival access to prescription drugs can be provided to low and middle income populations for all global diseases without harming innovation. Expand
The global drug gap.
Constructive solutions are needed that can both protect the incentives for research and development and reduce the inequities of access. Expand
The pharmaceutical industry as a medicines provider
Concerns about the harmful effects of the international system of intellectual property rights have led the World Trade Organization to relax the demands placed on least developed countries, and to advocate differential pricing of essential drugs, and how these actions will help countries that lack domestic production capacity is unclear. Expand
Regime Shifting: The TRIPs Agreement and New Dynamics of International Intellectual Property Lawmaking
This Article draws upon the international relations theory of regimes to analyze the growing chorus of challenges to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs),Expand